Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 06 Jun 2025

Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature

in Hematologic Malignancies

Shuang Yu
Xiangxin Li
Jun Peng
Luqun Wang
Hao Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1570981

2,761 views
1 citation

Editorial

Published on 06 Jun 2025

Editorial: Health-related quality of life among Hodgkin lymphoma survivors

in Hematologic Malignancies

Esther Natalie Oliva
Alberto Fabbri
Àrpàd Illès

Frontiers in Oncology

doi 10.3389/fonc.2025.1625160

1,341 views

Case Report

Published on 03 Jun 2025

Case Report: Epididymal NK/T-cell lymphoma and adrenal diffuse large B-cell lymphoma are misdiagnosed as tuberculosis: two case reports and literature review

in Hematologic Malignancies

Dan Ye
Xuhui Liu
Yuexiang Yang
Yang Yang
Zhentao Fei
Huarui Liu
Qilin Zhan
Lu Xia

Frontiers in Oncology

doi 10.3389/fonc.2025.1529049

2,336 views

Case Report

Published on 03 Jun 2025

Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review

in Hematologic Malignancies

Zhen Li
Sujing Zhuang
Ruirui Gui
Binglei Zhang
Wenli Zhang
Juan Wang
Yingling Zu
Fei Yang
Xiangke Xin
Yanyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585088

2,311 views

Case Report

Published on 27 May 2025

Unilateral sudden hearing loss as the first presenting symptom of chronic myeloid leukemia: a case report and literature review

in Hematologic Malignancies

Le Sun
Yue Yin
Xiang Guo
Fan Yu
Jinkun Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1579765

3,040 views
1 citation

Original Research

Published on 23 May 2025

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

in Hematologic Malignancies

Rui Liu
Fan Yang
Lixia Ma
Yuelu Guo
Miaomiao Cao
Zhonghua Fu
Biping Deng
Qinlong Zheng
Chen Chen
Danyang Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1566938

4,049 views
4 citations

Case Report

Published on 21 May 2025

Novel compound heterozygous PIEZO1 variants in dehydrated hereditary stomatocytosis initially suspected as myelodysplastic syndromes: a case report

in Hematologic Malignancies

Yongcheng Sun
Tao Wang
Shuyan Wang
Yan Chen
Zhijuan Xu
Cong Shi
Zanzan Wang
Guifang Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2025.1574518

2,189 views

Original Research

Published on 21 May 2025

Clinical characteristics of diffuse large B-cell lymphoma complicated with multiple primary malignant neoplasms

in Hematologic Malignancies

Mingxi Tian
Xuejiao Gu
Bin Lv
Yanhui Li
Ziqing Huang
Xinyi Li
Yan Zhang
Ying Wang
Feng Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592517

1,676 views

Original Research

Published on 15 May 2025

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma

in Hematologic Malignancies

Ahmed Salah
Hanafy Hafez
Samah Semary
Eman Naguib Khorshed
Sonia Soliman
Iman Zaky
Shahenda M. Shahin
Leslie Lehmann
Alaa ElHaddad

Frontiers in Oncology

doi 10.3389/fonc.2025.1569370

2,119 views

Original Research

Published on 15 May 2025

Divergent gene expression of PTGS1 and PTGS2 along the disease course of chronic myeloid leukaemia

in Hematologic Malignancies

Denise K. Wosniaki
Bianca N. Kusma
Anelis M. Marin
Eduardo C. Munhoz
João S. de H. Farias
Eduarda B. Mendes
Mateus N. Aoki
Dalila L. Zanette

Frontiers in Oncology

doi 10.3389/fonc.2025.1556956

2,262 views

Original Research

Published on 14 May 2025

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

in Hematologic Malignancies

Long Chang
Wen-Xin Li
Hao Cai
Jian Li
Ming-Hui Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1586839

3,691 views
1 citation

Original Research

Published on 14 May 2025

Hematological cancer patients’ social support, coping strategies, anxiety, depression and posttraumatic growth: a structural equation model

in Hematologic Malignancies

Taoyun Liang
Ling Mao
Xinwen Du
Fengjiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1540973

3,068 views
2 citations

Case Report

Published on 12 May 2025

Case Report: Sclerosing variant of extramedullary hematopoietic tumor primary arising in kidney, unexpected clinical and pathological presentation

in Hematologic Malignancies

Haneen Al-Maghrabi
Ghadeer Mokhtar
Feras Asali
Abdelrazak Meliti

Frontiers in Oncology

doi 10.3389/fonc.2025.1573784

1,653 views

Original Research

Published on 12 May 2025

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study

in Hematologic Malignancies

Yan Wang
Chun Chang
Zhen Wang
Jie Zhao
Jingbo Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1587185

2,725 views

Original Research

Published on 09 May 2025

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)

in Hematologic Malignancies

Ayman Alhejazi
Ahmad Alhuraiji
Abdulnaser Nourallah
Abdulrahman Alshehri
Binyam Usman
Ghada ElGohary
Hafiz Malhan
Ibraheem Motabi
Khalil Al Farsi
Mohammed Alshuaibi

Frontiers in Oncology

doi 10.3389/fonc.2025.1547138

4,250 views

Original Research

Published on 08 May 2025

Impact of secondary hematologic malignancies on prognosis of Hodgkin’s lymphoma survivors

in Hematologic Malignancies

Fangheng Lin
Debin Liu
Tao Huang
Yunlong Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1566063

1,942 views

Original Research

Published on 08 May 2025

CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience

in Hematologic Malignancies

Laura Mettivier
Danilo De Novellis
Anna Maria Della Corte
Bianca Serio
Luca Pezzullo
Roberto Guariglia
Idalucia Ferrara
Raffaele Fontana
Maria Carmen Martorelli
Serena Luponio

Frontiers in Oncology

doi 10.3389/fonc.2025.1569707

2,481 views

Review

Published on 08 May 2025

The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers

in Hematologic Malignancies

Anna Sicuranza
Alessia Cavalleri
Simona Bernardi

Frontiers in Oncology

doi 10.3389/fonc.2025.1546813

5,723 views
11 citations

Correction

Published on 06 May 2025

Corrigendum: Lipid have a direct effect on multiple myeloma: a Mendelian randomization study

in Hematologic Malignancies

Yingbin Zhong
Yanhao Li
Weipeng Sun
Mingfeng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2025.1603501

1,380 views

Case Report

Published on 02 May 2025

Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report

in Hematologic Malignancies

Xianfeng Ouyang
Jianguo Yan
Su Hu
Wenfeng Zhu
Qibao Zhou
Fei Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1529640

2,147 views
1 citation

Case Report

Published on 01 May 2025

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a patient with pre-existing essential thrombocythemia: a case report and literature review

in Hematologic Malignancies

Ying Wu
Dan Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1573893

2,587 views

Review

Published on 01 May 2025

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus

in Hematologic Malignancies

Tulika Seth
Sameer Melinkeri
Tuphan Kanti Dolai
Jina Bhattacharyya
Neeraj Sidharthan
Prantar Chakrabarti
Chaithanya Malalur
Santosh Taur

Frontiers in Oncology

doi 10.3389/fonc.2025.1546641

4,786 views
2 citations

Review

Published on 29 Apr 2025

A potential prognostic marker for hematologic neoplasms: CD58

in Hematologic Malignancies

Jiajia Cao
Yurong Zhang
Ningning Yue
Shuzhen Xiong
Shuni Zhang
Chongyang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1586842

3,326 views
1 citation

Original Research

Published on 28 Apr 2025

TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B–cell lymphoma

in Hematologic Malignancies

Yiping Jin
Yi Wang
Lu Wang
He Zhang
Beibei Ren
Jiawen Zheng
Qingxin Xia
Yanyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1550207

4,220 views
5 citations

2,074 articles

articles

Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature

Editorial: Health-related quality of life among Hodgkin lymphoma survivors

Case Report: Epididymal NK/T-cell lymphoma and adrenal diffuse large B-cell lymphoma are misdiagnosed as tuberculosis: two case reports and literature review

Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review

Unilateral sudden hearing loss as the first presenting symptom of chronic myeloid leukemia: a case report and literature review

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

Novel compound heterozygous PIEZO1 variants in dehydrated hereditary stomatocytosis initially suspected as myelodysplastic syndromes: a case report

Clinical characteristics of diffuse large B-cell lymphoma complicated with multiple primary malignant neoplasms

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma

Divergent gene expression of PTGS1 and PTGS2 along the disease course of chronic myeloid leukaemia

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

Hematological cancer patients’ social support, coping strategies, anxiety, depression and posttraumatic growth: a structural equation model

Case Report: Sclerosing variant of extramedullary hematopoietic tumor primary arising in kidney, unexpected clinical and pathological presentation

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study

Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study)

Impact of secondary hematologic malignancies on prognosis of Hodgkin’s lymphoma survivors

CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience

The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers

Corrigendum: Lipid have a direct effect on multiple myeloma: a Mendelian randomization study

Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a patient with pre-existing essential thrombocythemia: a case report and literature review

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus

A potential prognostic marker for hematologic neoplasms: CD58

TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B–cell lymphoma